Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Human Vaccines|April 8, 2010
Whole cell vaccination for meningococcus: Lessons from an idea whose time has goneJoseph E Labrie, Paul B KeiserHuman Vaccines & Immunotherapeutics|May 29, 2012
Meningococcal polysaccharide vaccine failure in a patient with C7 deficiency and a decreased anti-capsular antibody responsePaul B Keiser, Michael BroderickVaccine|August 25, 2010
A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcAPaul B Keiser, Barnett T Gibbs, Trinka S Coster, et al.Current Infectious Disease Reports|February 21, 2002
Update on Lymphatic Filarial InfectionsPaul B. Keiser, Thomas B. NutmanClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2003
Prolonged perilesional edema after treatment of parenchymal neurocysticercosis: methotrexate as a corticosteroid-sparing agentPaul B Keiser, Theodore E NashClinical Microbiology Reviews|January 17, 2004
Strongyloides stercoralis in the Immunocompromised PopulationPaul B Keiser, Thomas B NutmanMilitary Medicine|April 5, 2011
U.S. military fatalities due to Neisseria meningitidis: case reports and historical perspectivePaul B Keiser, Lanette Hamilton, Michael BroderickSeminars in Immunology|June 21, 2005
Bone marrow microenvironmental changes in aged mice compromise V(D)J recombinase activity and B cell generationJoseph E Labrie, Lisa Borghesi, Rachel M GersteinVaccine|July 24, 2010
Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccineWendell D Zollinger, Mikhail A Donets, Deborah H Schmiel, et al.Clinical and Vaccine Immunology : CVI|November 20, 2009
Evaluation of a whole-blood cytokine release assay for use in measuring endotoxin activity of group B Neisseria meningitidis vaccines made from lipid A acylation mutantsMark B Stoddard, Valerian Pinto, Paul B Keiser, et al.Pageof 4